Division of Clinical, Social and Administrative Sciences, Mylan School of Pharmacy, 418F Mellon Hall, Duquesne University, 600 Forbes Avenue, Pittsburgh, PA 15282, USA.
Health Qual Life Outcomes. 2012 Jan 31;10:14. doi: 10.1186/1477-7525-10-14.
Breast cancer is the most common cancer in women, representing 16% of all female cancers. According to the American Cancer Society, long-term cancer survival is defined as more than five years of survivorship since diagnosis, with approximately 2.5 million breast cancer survivors (BCS) in 2006. The long-term effects from breast cancer and its treatment have been shown to have positive and negative effects on both recovery and survivors' quality of life (QoL). The purpose of the study was to identify QoL instruments that have been validated in long-term BCS and to review the studies that have used the QoL instruments in this population.
A systematic literature search was conducted from January 1990 to October 2010 using electronic databases. Instruments validated and used in BCS were included in the review. In addition, QoL studies in long-term BCS using the validated instruments were reviewed. The search was limited to studies in English language. Studies of BCS of less than five years after initial diagnosis, any clinical or review studies were excluded.
The review identified a total of 12 instruments (10 disease-specific, 2 condition-specific) validated in long-term BCS. According to the QoL framework proposed by Ferrell and colleagues, three instruments (Quality of Life-Cancer Survivors, Quality of Life in Adult Cancer Survivors Scale, and Quality of Life Index-Cancer Version) evaluated all four domains (physical, psychological, social, and spiritual) of QoL. A review of the psychometric evaluation showed that Quality of Life in Adult Cancer Survivors Scale has acceptable reliability, validity, and responsiveness in long-term BCS compared to other disease-specific instruments. The review also yielded 19 studies that used these QoL instruments. The study results indicated that age-group, ethnicity, and type of treatment influenced different aspects of QoL.
There is a significant impact of breast cancer on QoL in long-term BCS. The review can help researchers and clinicians select the most appropriate instruments to assess the changes in QoL in BCS.
乳腺癌是女性最常见的癌症,占所有女性癌症的 16%。根据美国癌症协会的数据,长期癌症生存是指自诊断以来超过五年的生存,2006 年约有 250 万乳腺癌幸存者(BCS)。乳腺癌及其治疗的长期影响已被证明对恢复和幸存者的生活质量(QoL)既有积极影响,也有消极影响。本研究的目的是确定已在长期 BCS 中验证的 QoL 工具,并综述在该人群中使用这些 QoL 工具的研究。
从 1990 年 1 月至 2010 年 10 月,使用电子数据库进行了系统的文献检索。纳入了在 BCS 中经过验证和使用的工具。此外,还回顾了使用经过验证的工具进行的长期 BCS 的 QoL 研究。检索仅限于英语语言的研究。排除了初始诊断后少于 5 年的 BCS 研究以及任何临床或综述研究。
综述共确定了 12 种在长期 BCS 中经过验证的工具(10 种疾病特异性,2 种疾病特异性)。根据 Ferrell 及其同事提出的 QoL 框架,三种工具(癌症幸存者生活质量量表、成人癌症幸存者生活质量量表和癌症生活质量指数-癌症版本)评估了 QoL 的所有四个领域(身体、心理、社会和精神)。对心理测量评估的回顾表明,与其他疾病特异性工具相比,成人癌症幸存者生活质量量表在长期 BCS 中具有可接受的可靠性、有效性和反应性。综述还产生了 19 项使用这些 QoL 工具的研究。研究结果表明,年龄组、种族和治疗类型影响 QoL 的不同方面。
乳腺癌对长期 BCS 的 QoL 有重大影响。该综述可以帮助研究人员和临床医生选择最合适的工具来评估 BCS 中 QoL 的变化。